Core Viewpoint - Silo Wellness Inc. has appointed Richard Craven as CEO to lead the company's strategic transition to Born Defense Inc., focusing on defense and national security investments guided by the Just War Doctrine [1][3]. Company Overview - Silo Wellness is transitioning its operations into Born Defense Inc., which will operate as a national security investment issuer committed to ethical defense finance [5]. - The restructured business model will focus on trade finance, strategic equity investments, and collateral-backed lending for pre-IPO and critical infrastructure ventures globally [5]. Leadership Background - Richard Craven brings extensive experience in financial structuring and defense-related enterprise development, having previously managed over £11.2 billion in assets and annual inflows exceeding £4 billion at a major retail investment platform [2]. - Craven has held CEO responsibilities in defense-related companies and has executed significant U.S. defense system procurement agreements [2][3]. Strategic Importance - The appointment of Craven is seen as crucial for navigating complex defense transactions and enhancing the company's global regulatory posture [3]. - The transition to Born Defense is expected to close later in 2025, pending regulatory and shareholder approval [3].

Core Viewpoint - Silo Wellness Inc. is transitioning to "Born Defense," focusing on defense and national security investments, guided by the Just War Doctrine, aiming to end "forever wars" and promote responsible national self-defense [1][4]. Company Transition and Strategic Focus - Born Defense will invest in advanced defense technologies, including cybersecurity, autonomous systems, and advanced manufacturing, supporting Canada's defense sector growth in line with NATO's 2% GDP defense spending target by 2027 [2][6]. - The company plans to explore high-potential investments across North America and Europe, delivering ethical and scalable defense solutions [2]. Investment Strategy - The global defense market is projected to reach $676.64 billion by 2029, growing at a 6.4% CAGR, positioning Born Defense to capitalize on growth opportunities [5][6]. - The company aims to leverage strategic capital and deep industry networks to support innovative companies addressing modern security threats [5]. Geopolitical Context - Rising global tensions, including conflicts in Eastern Europe and cybersecurity threats, are driving demand for innovative defense solutions [6][7]. - Born Defense's commitment to ending "forever wars" aligns with the increasing investor interest in socially responsible opportunities [7]. Proposed Changes and Governance - The company will hold a shareholder meeting to approve the name change and elect a board with defense and national security expertise, resulting in a change of control [9]. - The completion of the proposed transaction is subject to various approvals, including financing and regulatory [10]. Divestment and Future Focus - The company plans to divest its psychedelic assets to focus resources on the defense industry, which is seen as having greater growth potential [11][13]. - There is an openness to explore investments in psychedelic therapy aligned with Department of Defense research for PTSD and traumatic brain injuries [11]. Funding and Compliance - Funding for necessary audits and listing statements has been secured, and the company is working to revoke a Cease Trade Order issued due to delayed financial filings [15].